The meta-analysis of multiple microarray datasets showed a significantly lower expression of LDHB in prostate adenocarcinomas compared with normal prostate glands (Median Rank: 160; p = 4.9 × 10−5; n = 973 patient samples), while LDHA expression levels presented no significant differences (Figure 5A). Here, LDHB is linked to prostate adenocarcinoma.